E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/17/2016 in the Prospect News PIPE Daily.

Innocoll prices its $40.08 million public offering of stock at $7.00

Morgan Stanley and Piper Jaffray help sell 5,725,000 ordinary shares

By Devika Patel

Knoxville, Tenn., June 17 – Innocoll Holdings plc said on Thursday that it priced a $40.08 million public sale of stock with a $6.01 million greenshoe. The deal was announced Monday.

The company will sell 5,725,000 ordinary shares at $7.00 per share. The price per share is a 14.74% discount to the June 15 closing share price of $8.21.

Morgan Stanley is the lead bookrunning manager and Piper Jaffray & Co. is the joint bookrunning manager.

Settlement is expected June 22.

The specialty pharmaceutical and medical device company is based in Athlone, Ireland.

Issuer:Innocoll Holdings plc
Issue:Ordinary stock
Amount:$40,075,000
Greenshoe:$6,011,250, or 858,750 shares
Shares:5,725,000
Price:$7.00
Warrants:No
Bookrunners:Morgan Stanley (lead) and Piper Jaffray & Co.
Lead manager:Stifel
Co-managers:FBR and Janney Montgomery Scott
Announcement date:June 13
Pricing date:June 16
Settlement date:June 22
Stock symbol:Nasdaq INNL
Stock price:$8.21 at close June 15
Market capitalization:$154.27 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.